Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes

BACKGROUND: Simplified maintenance therapy with ritonavir-boosted atazanavir (ATV/RTV) alone is attractive because of nucleoside reverse-transcriptase inhibitor (NRTI)–sparing benefits, low pill burden, once-daily dosage, and safety. METHODS: Subjects with virologic suppression after ≥48 weeks of in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wilkin, Timothy J., McKinnon, John E., DiRienzo, A. Gregory, Mollan, Katie, Fletcher, Courtney V., Margolis, David M., Bastow, Barbara, Thal, Gary, Woodward, William, Godfrey, Catherine, Wiegand, Ann, Maldarelli, Frank, Palmer, Sarah, Coffin, John M., Mellors, John W., Swindells, Susan
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2680942/
https://ncbi.nlm.nih.gov/pubmed/19191590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/597119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars